Novel small molecule oral antiviral could be a game-changer in the fight against future pandemics

FHS
June 4, 2024
7:17 pm

Obeldesivir (GS-5245), a novel investigational small molecule oral antiviral, represents a new tool in the ongoing effort to prepare for future pandemics.

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Researchers performed a phase III randomized clinical trial (RCT).

June 29, 2023

Doc Who Said COVID Vax Magnetized People Has License Suspended

The State Medical Board of Ohio voted to suspend the medical license of Sherri Tenpenny, DO, on Wednesday, after she failed to cooperate with an

August 12, 2023

Life expectancy in India suffered large and unequal declines during COVID-19 pandemic

The international study, co-authored by the Department of Sociology and the Leverhulme Centre for Demographic Science’s Dr Aashish Gupta and Professor Ridhi Kashyap, reveals that

July 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.